NCT01618734View on ClinicalTrials.gov

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Immune ThrombocytopeniaThrombopoietin Receptor Agonist
All Listed Sponsors
collaborator

Paris 12 Val de Marne University

OTHER

lead

Henri Mondor University Hospital

OTHER

NCT01618734 - Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety. | Biotech Hunter | Biotech Hunter